Journal
JOURNAL OF CLINICAL MICROBIOLOGY
Volume 43, Issue 7, Pages 3530-3532Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/JCM.43.7.3530-3532.2005
Keywords
-
Categories
Funding
- FIC NIH HHS [K01 TW000001, K01 TW000001-06, TW 06083-01, K01 TW006083] Funding Source: Medline
- NIAID NIH HHS [AI 34238, R01 AI034238] Funding Source: Medline
Ask authors/readers for more resources
Mycobacterium bovis is best identified by screening those isolates of the Mycobacterium tuberculosis complex that have any pyrazinamide-(PZA) resistance, using a confirmatory test such as spoligotyping, biochemical testing, or genomic deletion analysis. The sensitivity for detection of M. bovis is lowered to 82% when only PZA-monoresistant isolates are screened.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
